109 related articles for article (PubMed ID: 24002581)
21. Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype.
Wang H; Wang Y; Jiang C
Int J Oncol; 2013 May; 42(5):1716-24. PubMed ID: 23467707
[TBL] [Abstract][Full Text] [Related]
22. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
23. Human leukocyte antigen-G overexpression predicts poor clinical outcomes in low-grade gliomas.
Fan X; Wang Y; Zhang C; Liu X; Qian Z; Jiang T
J Neuroimmunol; 2016 May; 294():27-31. PubMed ID: 27138095
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract][Full Text] [Related]
25. Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence.
Liao P; Ostrom QT; Stetson L; Barnholtz-Sloan JS
Neuro Oncol; 2018 Jun; 20(7):942-953. PubMed ID: 29432558
[TBL] [Abstract][Full Text] [Related]
26. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
Mur P; Rodríguez de Lope Á; Díaz-Crespo FJ; Hernández-Iglesias T; Ribalta T; Fiaño C; García JF; Rey JA; Mollejo M; Meléndez B
J Neurooncol; 2015 May; 122(3):441-50. PubMed ID: 25682093
[TBL] [Abstract][Full Text] [Related]
27. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
28. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.
Broniscer A; Baker SJ; West AN; Fraser MM; Proko E; Kocak M; Dalton J; Zambetti GP; Ellison DW; Kun LE; Gajjar A; Gilbertson RJ; Fuller CE
J Clin Oncol; 2007 Feb; 25(6):682-9. PubMed ID: 17308273
[TBL] [Abstract][Full Text] [Related]
30. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
[TBL] [Abstract][Full Text] [Related]
31. CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma.
Sibin MK; Bhat DI; Narasingarao KV; Lavanya Ch; Chetan GK
Tumour Biol; 2015 Sep; 36(10):7607-14. PubMed ID: 25921285
[TBL] [Abstract][Full Text] [Related]
32. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
33. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
34. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas.
Coppola D; Balducci L; Chen DT; Loboda A; Nebozhyn M; Staller A; Fulp WJ; Dalton W; Yeatman T; Brem S
J Geriatr Oncol; 2014 Oct; 5(4):389-99. PubMed ID: 25220188
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade.
Teng Y; Dong YC; Liu Z; Zou Y; Xie H; Zhao Y; Su J; Cao F; Jin H; Ren H
Int J Mol Med; 2017 Mar; 39(3):725-733. PubMed ID: 28204824
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation.
Fukushima S; Yoshida A; Honda K; Maeshima AM; Narita Y; Yamada T; Shibui S; Tsuda H
Brain Tumor Pathol; 2014 Jan; 31(1):11-6. PubMed ID: 23504125
[TBL] [Abstract][Full Text] [Related]
38. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
Xia Z; Liu F; Zhang J; Liu L
PLoS One; 2015; 10(7):e0132399. PubMed ID: 26134825
[TBL] [Abstract][Full Text] [Related]
39. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
40. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
